𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pre-treatment global quality of health predicts progression free survival in metastatic kidney cancer patients treated with sorafenib or sunitinib

✍ Scribed by Edwin Herrmann; Joachim Gerss; Stefan Bierer; Thomas Köpke; Christian Bolenz; Lothar Hertle; Christian Wülfing


Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
315 KB
Volume
135
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.